Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential

Published:2003-03-01 Issue:1 Volume:55 Page:133-166
ISSN:0031-6997
Container-title:Pharmacological Reviews
language:en
Short-container-title:Pharmacol Rev

Author:

Von der Thüsen Jan H.,Kuiper Johan,Van Berkel Theo J. C.,Biessen Erik A. L.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference558 articles.

1. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells.;Aarvak;J Immunol,1999

2. Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation.;Abraham;Clin Exp Immunol,1994

3. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κB

4. AF12198, a Novel Low Molecular Weight Antagonist, Selectively Binds the Human Type I Interleukin (IL)-1 Receptor and Blocks in Vivo Responses to IL-1

5. Role of interleukin-6 in macrophage function

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review;Endocrine Practice;2023-06

2. Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction;European Journal of Preventive Cardiology;2023-01-25

3. Biomarkers for Premature Coronary Artery Disease (PCAD): A Case Control Study;Diagnostics;2023-01-04

4. CHRONIC ORAL TRIMETHYLAMINE-N-OXIDE ADMINISTRATION INDUCES EXPERIMENTAL INCIPIENT ATHEROSCLEROSIS IN NON-GENETICALLY MODIFIED MICE;J PHYSIOL PHARMACOL;2022

5. Biochemical and clinical evaluation of endothelial injury after distal or traditional transradial access in percutaneous interventions;Kardiologia Polska;2022-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3